Enlisting Apple Devices and ResearchKit to Study Opioid Addiction

by Jonathan Collins | 2Q 2017 | IN-4541

A new study launched by Purdue Pharmaceuticals, maker of the popular and addiction-linked opioid OxyContin, has plans to turn to Apple in a study of medication adherence and varying approaches to clinical programs for pain management.

You must be a subscriber to view this Insight.

To find out more about subscribing:
Contact a representative about purchasing options.